Condition
Cell Free DNA
Total Trials
5
Recruiting
3
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting3
Active Not Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07770659Recruiting
Non-invasive Prediction of EArly Cardiac rEjection
NCT07224854Active Not Recruiting
Epigenetic Signature for CRC Early Detection
NCT07471373Not ApplicableRecruiting
Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Women With Endometriosis
NCT07493928Recruiting
HPV After chemoRadioTherapy
NCT05815134Not ApplicableCompleted
Cell Free DNA Quantification in Patients With Endometriosis Followed Witd Medical Assistance to Procreation
Showing all 5 trials